Talcum Powder

Another Study Links Talcum Powder to Ovarian Cancer

Read More

PPI Drugs Linked to Kidney Disease

Correlation Between Prevalent Heartburn & Stomach Acid Drugs and Kidney Disease

Read More

Transvaginal Mesh

Attorneys General Sue Johnson & Johnson over Pelvic Mesh Complications

Read More

Pharma Perks to Prescribing Name-Brand Drugs

Correlation Between Prevalent Heartburn & Stomach Acid Drugs and Kidney Disease

Read More

Xarelto

Recent Studies Continue to Illustrate Bleeding Risk

Read More

Zofran

Marketed to Pregnant Women Linked to Birth Defects

Read More

Testosterone

FDA Orders New Warnings and Clinical Studies

Read More

Stryker Corp. Hip Implant

FDA Issues Class I Recall For Stryker Device Used In Spinal Surgeries

Read More

News

Report: Medical Device Manufacturers Misclassify Patient Deaths in Reporting to FDA

Most people reasonably believe that when a product is cleared by the Food and Drug Administration, there has at least been some kind of independent review of the product. Many probably assume that the review is ongoing, so long as the product remains in use. Unfortunately, this is rarely true. The FDA relies on pharmaceutical companies to be truthful about their own products. As expected, profits and human error can get in the way.

More Than Fifteen Million Americans Use Heartburn Drugs Each Year – Why Weren’t They Warned About Possible Kidney Injury?

You’ve seen the commercials: one pill a day—zero heartburn! Maybe you even read the previous sentence in the voice of Larry the Cable Guy. But what you haven’t seen in those commercials are the risks. Because over-the-counter medications are regulated differently than prescription medications, the “OTC” versions of popular heartburn medicines are not required to disclose in commercials the potential health risks associated with the drugs.

Even More Warnings for Transvaginal Mesh

Boston Scientific Corporation announced this summer that it is once again adding new warnings to the labels for its surgical mesh devices. According to the Minneapolis Star Tribune, the products will now warn of “ongoing pain.” The labels will also finally disclose that mesh devices are permanent implants, that removal may be complicated or impossible, and that treatment for post-implant complications may require surgical removal of the device.

RECENT STUDIES ON XARELTO CONTINUE TO ILLUSTRATE BLEEDING RISKS

Bayer Healthcare previously “raised its forecast for Xarelto’s 2015 sales growth to 30 percent from 20 percent,” according to a report by Reuters. Xarelto is the heavily-advertised anticoagulant drug produced by Bayer and Johnson & Johnson’s pharmaceutical wing.

Sean Keith

Sean Keith is a native of Rogers, Arkansas and a second generation attorney. Sean completed his undergraduate degree at Westminster College in Fulton, Missouri, and received his law degree from the University of Arkansas at Fayetteville. Read More

Mason Boling

Mason Boling primarily represents plaintiffs in personal injury claims against pharmaceutical and medical device companies. He also writes appeals for both civil and criminal cases and assists in other forms of civil litigation and criminal defense. Read More

BENTON COUNTY

479.621.0006

Poplar Plaza Building
224 South 2nd St.
Rogers, AR 72756

WASHINGTON COUNTY

479.935.4995

Ball Plaza Building
112 W. Center St. #555
Fayetteville, AR 72701

Get A Case Review!